KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares Issued
Ratios

Recursion Pharmaceuticals (RXRX) Shares Issued (2020 - 2025)

Historic Shares Issued for Recursion Pharmaceuticals (RXRX) over the last 6 years, with Q3 2025 value amounting to $254.5 million.

  • Recursion Pharmaceuticals' Shares Issued rose 139964.64% to $254.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $406.5 million, marking a year-over-year increase of 1062.21%. This contributed to the annual value of $300.4 million for FY2024, which is 13453.04% up from last year.
  • Recursion Pharmaceuticals' Shares Issued amounted to $254.5 million in Q3 2025, which was up 139964.64% from $100.0 million recorded in Q2 2025.
  • Over the past 5 years, Recursion Pharmaceuticals' Shares Issued peaked at $460.7 million during Q2 2021, and registered a low of $1.9 million during Q1 2023.
  • In the last 5 years, Recursion Pharmaceuticals' Shares Issued had a median value of $17.0 million in 2024 and averaged $84.2 million.
  • As far as peak fluctuations go, Recursion Pharmaceuticals' Shares Issued skyrocketed by 1336250.0% in 2021, and later tumbled by 9941.62% in 2022.
  • Quarter analysis of 5 years shows Recursion Pharmaceuticals' Shares Issued stood at $460.7 million in 2021, then crashed by 70.36% to $136.6 million in 2022, then tumbled by 42.81% to $78.1 million in 2023, then crashed by 85.88% to $11.0 million in 2024, then soared by 2206.98% to $254.5 million in 2025.
  • Its Shares Issued stands at $254.5 million for Q3 2025, versus $100.0 million for Q2 2025 and $41.0 million for Q1 2025.